Letter: unknown denominator and misleading conclusions in COVID-19

Manuel Rodríguez-Perálvarez^{1

2}, Magdalena Salcedo^{2

3}, José Antonio Pons⁴, Jordi Colmenero^{2

5}; Spanish Society of Liver Transplantation (SETH)

Affiliations

¹ Department of Hepatology and Liver Transplantation, Hospital Universitario Reina sofía, IMIBIC, Córdoba, Spain.
² Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
³ Hepatology and Liver Transplantation Unit, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain.
⁴ Liver Transplantation Unit, Liver Unit, Department of Surgery, IMIB, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
⁵ Liver Transplant Unit, Hospital Clínic, IDIBAPS, University of Barcelona (Spain), Barcelona, Spain.

Comment

Manuel Rodríguez-Perálvarez et al. Aliment Pharmacol Ther. 2020 Oct.

. 2020 Oct;52(7):1241-1242.

doi: 10.1111/apt.16038.

Manuel Rodríguez-Perálvarez^{1

2}, Magdalena Salcedo^{2

3}, José Antonio Pons⁴, Jordi Colmenero^{2

5}; Spanish Society of Liver Transplantation (SETH)

¹ Department of Hepatology and Liver Transplantation, Hospital Universitario Reina sofía, IMIBIC, Córdoba, Spain.
² Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
³ Hepatology and Liver Transplantation Unit, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain.
⁴ Liver Transplantation Unit, Liver Unit, Department of Surgery, IMIB, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
⁵ Liver Transplant Unit, Hospital Clínic, IDIBAPS, University of Barcelona (Spain), Barcelona, Spain.

No abstract available

Comment in

Letter: unknown denominator and misleading conclusions in Covid-19-authors' reply.
Garrido I, Liberal R, Macedo G. Garrido I, et al. Aliment Pharmacol Ther. 2020 Oct;52(7):1243-1244. doi: 10.1111/apt.16056. Aliment Pharmacol Ther. 2020. PMID: 33016541 No abstract available.

Review article: COVID-19 and liver disease-what we know on 1st May 2020.
Garrido I, Liberal R, Macedo G. Garrido I, et al. Aliment Pharmacol Ther. 2020 Jul;52(2):267-275. doi: 10.1111/apt.15813. Epub 2020 Jun 2. Aliment Pharmacol Ther. 2020. PMID: 32402090 Free PMC article. Review.

1. Garrido I, Liberal R, Macedo G. Review article: COVID-19 and liver disease - what we know on 1st May 2020. Aliment Pharmacol Ther. 2020;52:267-275.
1. Colmenero J, Rodriguez-Perálvarez M, Salcedo M, et al. Epidemiological pattern, incidence and outcomes of Covid-19 in liver transplant patients. J Hepatol. 2020. (In press).
1. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. 382:1708-1720.
1. Taylor P. Standardized mortality ratios. Int J Epidemiol. 2013;42:1882-1890.
1. Tanaka Y, Sato Y, Sasaki T. Suppression of coronavirus replication by cyclophilin inhibitors. Viruses. 2013;5:1250-1260.